Curcumin Analog Pentagamaboronon-0-Sorbitol Inhibits Cell Migration Activity of Triple Negative Breast Cancer Cell Line

Ratna Dwi Ramadani, Rohmad Yudi Utomo, Adam Hermawan, Edy Meiyanto

Abstract


Mortality in cancer is primarily due to failure of metastasis prevention. One strategy to target the cancerous cell is Boron Neutron Captured Therapy which showed high affinity toward cancer cells and reported to have anti-proliferative as well as antimetastatic activities. Cancer Chemoprevention Research Center Faculty of Pharmacy Universitas Gadjah Mada, has developed boron-containing substance namely pentagamaboronon-0 (PGB-0) which is known to exhibit anticancer activity towards breast cancer cell. The purposes of this research are focused to explore the anti-migratory activities of PGB-0-So against triple negative breast cancer cell. The MTT cytotoxicity assay of PGB-0-So against 4T1 breast cancer cell line were found to exert potential effect in dose-dependent manner with IC50 values of 39 μM. The study of cell migration inhibition using in vitro wound healing assays and gelatin zymography on highly metastasis breast cancer cell line 4T1, following the treatment of sub IC50 doses of PGB-0-So complex slightly inhibited cell migration through the inhibition of matrix metalloproteinase-9 expression. These findings suggest that PGB-0-So is potential as an anticancer agent.

Keywords : curcumin analogue, PGB-0-So, 4T1 Cells, migration, MMP-9

 


Full Text:

PDF

References


Amalina, N.D., Nurhayati, I.P., and Meiyanto, E., 2017, Doxorubicin Induces Lamellipodia Formation and Cell Migration, Indones. J.Cancer Chemoprevent., 8(2), 61–67. CrossRef

Bandyopadhyay, A., Wang, L., Agyin, J., Tang, Y., Lin, S., Yeh, I.T., et al., 2010, Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models, PLoS ONE, 5(4), e10365. CrossRef

Baribeau, S., Chaudhry, P., Parent, S., and Asselin, É, 2014, Resveratrol Inhibits Cisplatin-inducedEpithelial-to mesenchymal Transition in Ovarian Cancer Cell Lines, PloS ONE, 9(1), e86987. CrossRef

Bhatnagar, B., Gilmore, S., Gloubeva, O., Pelser, C., Medeiros, M., Chumsri, S., et al., 2014, Chemotherapy Dose Reduction Due to Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients Receiving Chemotherapy

in The Neoadjuvantar Adjuvant Settings: A Single-center Experience, SpingerPlus, 3, 366. CrossRef

Bradke, T.M., Hall, C., Carper, S.W., and Plopper, G.E., 2008, Phenylboronic Acid Selectively Inhibits Human Prostate and Breast Cancer Cell Migration and Decreases Viability, Cell Adhes. Migr., 2(3), 153–160. CrossRef

Calvo, M.B., Figueroa, A., Pulido, E.G., Campelo, R.G., and Aparicio, L.A., 2010, Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy, Int. J. Endocrinol, 2010, 1-14. CrossRef

Cao, J., Han, Z., Tian, L., Chen, K., Fan, Y., Ye, B., et al., 2014, Curcumin Inhibits EMMPRIN and MMP-9 Expression Through AMPK-MAPK and PKC Signaling in PMA Induced Macrophages, J. Transl. Med., 12, 266. CrossRef

Carvalho, C., Santos, R.X., Cardoso, S., Correia, S., Oliveira, P.L., Santos, M.S., et al., 2009, Doxorubicin: The Good, the Bad and the Ugly Effect, Current Med. Chem., 16(25), 3267-3286. CrossRef

Chen, B.G., Zhang, M.Y., Zhao, Y.Y., Zhang, J., and Sun, C.C., 2006, Structural and Electronic Properties of BPA-fructose Complex Used in Boron Neutron Capture Therapy, J. Mol. Struct. THEOCHEM, 766, 35–40. CrossRef

Da’i, M., Suhendi, A., Meiyanto, E., Jenie, U.A., and Kawaichi, M., 2017, Apoptosis Induction Effect of Curcumin and Its Analogs Pentagamavunon-0 and Pentagamavunon-1 On Cancer Cell LINES, Asian J. Pharm. Clin. Res., 10(3), 373–376. CrossRef

Dai, M., Margono, S.A., Jenie, U.A., Kawaichi, M. and Meiyanto, E, 2011, Pentagamavunon-1 Menghambat Siklus Sel T47D Terinduksi Caspase Inhibitor Z-Vad-Fmk pada Fase G2/M, Jurnal Farmasi Indonesia, 4(5), 180-187. Link

Dawood, S., Merajver, S.D., Viens, P., Vermeulen, P.B., Swain, S.M., et al., 2010, International Expert Panel on Inflammatory Breast Cancer: Consensus Statement for Standardized Diagnosis and Treatment, Ann. Oncol., 22(3), 515-523. CrossRef

de Ruijter, T.C., Veeck, J., de Hoon, J.P.J., van Engeland, M., and Tjan-Heijnen, V.C., 2011, Characteristics of Triple negative Breast Cancer, J. Cancer Res. Clin. Oncol., 137(2), 183–192. CrossRef

DuPré, S.A., Redelman, D., and Hunter, K.W., 2007, The Mouse Mammary Carcinoma 4T1: Characterization of The Cellular Landscape of Primary Tumours and Metastatic Tumour Foci, Int. J. Exp. Pathol., 88(5), 351–360. CrossRef

Fan, X., Liu, H., Liu, M., Wang, Y., Qiu, L., and Cui, Y., 2017, Increased Utilization of Fructose has A Positive Effect on The Development of Breast Cancer, PeerJ., 5, e3804. CrossRef

Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., and Mathers, C., 2013, GLOBOOCAN 2012 Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11, Lyon: International Agency for Research on Cancer.

Gavilá, J., Lopez-Tarruella, S., Saura, C., Muñoz, M., Oliveira, M., De la Cruz-Merino, L., et al., 2015, SEOM Clinical Guidelines in Metastatic Breast Cancer 2015, Clin. Transl. Oncol., 17(12), 946–955. CrossRef

Heppner, G.H., Miller, F.R., Shekhar, P.V.M., 2000, Nontransgenic Models of Breast Cancer, Breast Cancer Res., 2(5), 331–334. CrossRef

Hermawan, A., Fitriasari, A., Junedi, S., Ikawati, M., Haryanti, S., Widaryanti, B., et al., 2011, PGV-0 and PGV-1 Increase Apoptosis Induction of Doxorubicin on MCF-7 Breast Cancer Cells, Pharm. J. Indones., 2(12), 55-59.

LaHann, T.R., Lu, D.R., Daniell, G., Sills, C., Kraft, S.L., Gavin, P.R., et al., 1993., Bioavailability of Intravenous Formulations of P-Boronophenylalanine in Dog and Rat, In: Advances in Neutron Capture Therapy, Boston: Springer, pp.585–589. CrossRef

Macheda, M.L., Rogers, S., and Best, J.D., 2005, Molecular and Cellular Regulation of Glucose Transporter (GLUT) Proteins in Cancer, J. Cell. Physiol., 202(3), 654–662. CrossRef

Mallesch, J.L., Moore, D.E., Allen, B.J., McCarthy, W.H., Jones, R., and Stening, W.A., 1994, The Pharmacokinetics of p-Boronophenylalanine Fructose in Human Patients with Glioma and Metastatic Melanoma, Int. J. Radiat. Oncol. Biol. Phys., 28, 1183–1188. CrossRef

McAuley, E.M., Bradke, T.A., and Plopper, G.E., 2011, Phenylboronic Acid is A More Potent Inhibitor Than Boric Acid of Key Signaling Networks Involved in Cancer Cell Migration, Cell Adhes. Migr., 5(5), 382–386. CrossRef

Meiyanto, E., Supardjan, Dai, M., and Agustina, D., 2006, Antiproliferative Effect of Pentagamavunon-0 on Breast Cancer Cell Line T47D, Jurnal Kedokteran YARSI, 14(1), 11-15.

Meiyanto, E., Putri, D.D., Susidarti, R.A., Murwanti, R., Sardjiman, Fitriasari, A., et al., 2014, Curcumin and Its Analogues (PGV-0 and PGV-1) Enhance Sensitivity of Resistant MCF-7 Cells to Doxorubicin Through Inhibition of HER2 and NFkB Activation, Asian Pac. J. Cancer Prev., 15(1), 179–184. CrossRef

Nurulita, N.A. and Meiyanto, E. 2006, The Anticancer Effects of Pentagamavunon-0 (PGV-0) to T47D Cell Line Induced by 17-B-Estradiol Through Apoptosis Induction and Angiogenesis suppression Mechanism, Sains Kesehatan, 19(1), 109-125. Link

Moirangthem, A., Bondhopadhyay, B., Mukherjee, M., Bandyopadhyay, A., Mukherjee, N., Konar, K., et al., 2016, Simultaneous Knockdown of uPA and MMP9 Can Reduce Breast Cancer Progression by Increasing Cell-cell Adhesion and Modulating EMT Genes, Sci. Rep., 6, 21903. CrossRef

Pedrycz, A. and Kramkowska, A., 2016, Adriamycin- Efficacy and Possible Adverse Effects, Curr. Probl. Psychiatry, 17(1), 38–46. CrossRef

Pulaski, B.A. and Ostrand-Rosenberg, S., 2000, Mouse 4T1 Breast Tumor Model, Curr. Protoc. Immunol., 20, 20.2.1-20.2.16. CrossRef

Putri, H., Jenie, R.I., Handayani, S., Kastian, R.F., and Meiyanto, E., 2016, Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells, Asian Pac. J. Cancer Prev., 17(5), 2683–2688. Link

Song, J., Su, H., Zhou, Y.Y., and Guo, L.L., 2013, Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A metaanalysis, Asian Pac. J. Cancer Prev., 14(3),1615–1621. CrossRef

Thorn, C.F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T.T., et al., 2011, Doxorubicin Pathways: Pharmacodynamics and Adverse Effects, Pharmacogenet. Genomics., 21(7), 440-446. CrossRef

Utomo, R.Y., Putri, H., Pudjono, P., Susidarti, R.A., Jenie, R.I., and Meiyanto, E., 2017, Synthesis and Cytotoxic Activity of 2,5-Bis(4-Boronic Acid)Benzylidine Cyclopentanone nn Her2 Overexpressed-Cancer Cells, Indones. J. Pharm., 28(2), 74. CrossRef

Vandooren, J., Van den Steen, P.E., and Opdenakker, G., 2013, Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9): The Next Decade, Crit. Rev. Biochem. Mol. Biol., 48(3), 222–272. CrossRef

Yabluchanskiy, A., Yonggang, M., Iyer, R.P., Hall, M.E., and Lindsey, M.L., 2013, Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease, Physiology, 28(6), 391- 403. CrossRef

Yerlikaya, A. and Erin, N, 2008, Differential Sensitivity of Breast Cancer and Melanoma Cells to Proteasome Inhibitor Velcade, Int. J. Mol. Med., 22(6), 817-823. CrossRef

Yoshino, K., Suzuki, A., Mori, Y., Kakihana, H., Honda, C., Mishima, Y., et al., 1989, Improvement of Solubility of p-boronophenylalanine by Complex Formation with Monosaccharides, Strahlenther. Onkol., 165(2-3), 127–129.

Zamora-León, S.P., Golde, D.W., Concha, I.I., Rivas, C.I., Delgado-López, F., Baselga, J., et al., 1996, Expression of The Fructose Transporter GLUT5 in Human Breast Cancer, Proc. Natl. Acad. Sci. USA, 93(26), 1847–1852. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev9iss3pp%25p

Copyright (c) 2018 Ratna Dwi Ramadani

Indexed by:

               

                  

         

 

Indonesian Society for Cancer Chemoprevention